Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F8XU
|
|||
| Drug Name |
Isoindoline derivative 2
|
|||
| Synonyms |
PMID30185082-Compound-67
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
COGNITION THERAPEUTICS, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H23Cl2NO2
|
|||
| Canonical SMILES |
CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
|
|||
| InChI |
1S/C20H23Cl2NO2/c1-13(4-5-14-6-7-17(21)18(22)8-14)23-11-15-9-19(24-2)20(25-3)10-16(15)12-23/h6-10,13H,4-5,11-12H2,1-3H3/t13-/m1/s1
|
|||
| InChIKey |
QOXCLDKXSCBOOF-CYBMUJFWSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Ligand | [1] |
| Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] | |
| Voltage-gated potassium channel Kv11.1 (KCNH2) | Target Info | Ligand | [1] | |
| Target's Patent Info | Opioid receptor sigma 1 (OPRS1) | Target's Patent Info | [1] | |
| Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] | ||
| Voltage-gated potassium channel Kv11.1 (KCNH2) | Target's Patent Info | [1] | ||
| Pathwhiz Pathway | Muscle/Heart Contraction | |||
| Reactome | Voltage gated Potassium channels | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Hematopoietic Stem Cell Differentiation | ||||
| Potassium Channels | ||||
| miR-targeted genes in squamous cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.